In the past, QCOR has done well in a weak market. but lately it just seems to be trying to find a bottom. Could be 33. But lot of us thought it was 36, 35, 34, etc. I do think we are close. If i had to guess I'd say we are there or poss. 32 area.
Biotech in general, not just QCOR, can do very well in an environment like this. They are actually viewed as defensive plays now days, because the possibilities for growth, at least in the good one's is not diminished regardless of economic conditions. In addition, with millions more set to be covered under the Affordable Care Act, growth seems imminent.